Efficacy of hypertonic saline solution in infant with acute bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
The in vitro effect of nebulised hypertonic saline on human bronchial epithelium Source: Eur Respir J, 51 (5) 1702652; 10.1183/13993003.02652-2017 Year: 2018
Effect of inhaled hypertonic saline solution to treat infants hospitalized with viral bronchiolitis Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
Recovery and refractoriness following hypertonic saline challenge in asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Effects of nebulizer therapy by hypertonic saline, gender and breastfeeding on evolution of acute bronchiolitis Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005
Refractoriness following hypertonic saline challenge attenuates nocturnal asthma Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
The effect of hypertonic saline dextran solutions on hypoxic pulmonary vasoconstriction in anaesthetised piglets Source: Eur Respir J 2002; 20: 965-971 Year: 2002
Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 6 (1) 00130-2019; 10.1183/23120541.00130-2019 Year: 2020
A small audio device may be alternative to hypertonic saline inhalation for sputum induction in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
Short term tolerance of hypertonic saline aerosol delivered intranasally Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007
Hyaluronic acid improves tolerability to 7% hypertonic saline solution in bronchiectasis patients Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis Source: ERJ Open Res, 6 (3) 00269-2020; 10.1183/23120541.00269-2020 Year: 2020
Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
Role of pleural irrigation with normal saline versus streptokinase in complicated pleural effusions. Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019
Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis? Source: Eur Respir J, 51 (5) 1800755; 10.1183/13993003.00755-2018 Year: 2018
The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020
Effect of continuous versus bolus nasogastric tube feeding in ventilated patients Source: Annual Congress 2007 - Nursing interventions in the prevention and management of respiratory disease Year: 2007
Randomized parallel arm study to compare intrapleural instillation of streptokinase versus saline wash in loculated empyema thoracis . Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021
Oxygen saturation decrease after both isotonic and hypertonic saline inhalation in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 698s Year: 2005